How effective is Glimepiride for Type 1 Diabetes? (by duration, gender, age)

Summary:

Overall ratings: 3/5
Long term ratings: 3.3/5

This is a phase IV clinical study of how effective Glimepiride (glimepiride) is for Type 1 diabetes and for what kind of people. The study is created by eHealthMe from 13 Glimepiride users and is updated continuously.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Aug, 19, 2022

13 people are studied for taking Glimepiride in Type 1 diabetes


What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 38,843 Glimepiride users for its effectiveness, alternative drugs and more.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 1,734 drugs and 1,381 conditions by eHealthMe.

Overall effectiveness (number of people):

Does Glimepiride work for your Type 1 diabetes (overall)?

Long term (1+ years) effectiveness (number of people):

Does Glimepiride work for your Type 1 diabetes (long term)?

Glimepiride effectiveness for Type 1 diabetes (number of people):

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 9
  • high: 2
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 4
  • high: 2
  • very high: 0

Gender of people who take Glimepiride for Type 1 diabetes *:

  • female: 69.23 %
  • male: 30.77 %

Age of people who take Glimepiride for Type 1 diabetes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 7.69 %
  • 40-49: 7.69 %
  • 50-59: 23.08 %
  • 60+: 61.54 %

Who find Glimepiride more effective for Type 1 Diabetes?

Gender of people who take Glimepiride for Type 1 diabetes *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Glimepiride for Type 1 diabetes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride?

- You can start a phase IV clinical trial to monitor Glimepiride safety and effectiveness.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on glimepiride (the active ingredients of Glimepiride) and Glimepiride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: